IN-VITRO SUSCEPTIBILITY OF 124 XANTHOMONAS-MALTOPHILIA (STENOTROPHOMONAS-MALTOPHILIA) ISOLATES - COMPARISON OF THE AGAR DILUTION METHOD WITH THE E-TEST AND 2 AGAR DIFFUSION METHODS
M. Arpi et al., IN-VITRO SUSCEPTIBILITY OF 124 XANTHOMONAS-MALTOPHILIA (STENOTROPHOMONAS-MALTOPHILIA) ISOLATES - COMPARISON OF THE AGAR DILUTION METHOD WITH THE E-TEST AND 2 AGAR DIFFUSION METHODS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 104(2), 1996, pp. 108-114
The in vitro susceptibility of 124 Xanthomonas maltophilia isolates wa
s tested by four methods: Agar dilution (reference method), E-test, a
disk diffusion and a tablet diffusion method. Trimethoprim-sulfamethox
azole had the highest activity against X. maltophilia, followed by a c
ombination of aztreonam-clavulanic acid at different ratios, the ratio
1:1 being the most active with a susceptibility rate of 85% as compar
ed to 2% for aztreonam alone. Addition of the beta-lactamase inhibitor
tazobactam to piperacillin enhanced the rate of susceptible isolates
from 31% to 53%. Relatively few isolates were susceptible to ciproflox
acin (27%) and gentamicin (9%). Generally, the disk diffusion method h
ad a considerably higher frequency of ''very major'' discrepancies whe
n compared with the agar dilution method than with the other methods.
The susceptibility of X. maltophilia to trimethoprim-sulfame-thoxazole
and ciprofloxacin could reliably be determined by all the diffusion m
ethods tested, but otherwise the agar dilution method is to be preferr
ed. A standardized and reliable diffusion method for susceptibility te
sting of X. maltophilia remains to be found. Trimethoprim-sulfamethoxa
zole must be considered the drug of choice in the treatment of severe
X. maltophilia infections. The combination aztreonam-clavulanic acid i
s promising, but must be proved in a clinical setting.